Screening out molecular pathways and prognostic biomarkers of ultraviolet-mediated melanoma through computational techniques

Md Arju Hossain,Asif Ahsan,Md Imran Hasan,Md Sohel,Md Arif Khan,Pratul Dipta Somadder,Sumaiya Monjur,Md Sipon Miah,K M Kaderi Kibria,Kawsar Ahmed,Md Habibur Rahman,Md. Arju Hossain,Md. Imran Hasan,Md. Arif Khan,K. M. Kaderi Kibria
DOI: https://doi.org/10.1177/03936155241230968
2024-02-29
The International Journal of Biological Markers
Abstract:The International Journal of Biological Markers, Ahead of Print. PurposeUltraviolet radiation causes skin cancer, but the exact mechanism by which it occurs and the most effective methods of intervention to prevent it are yet unknown. For this purpose, our study will use bioinformatics and systems biology approaches to discover potential biomarkers of skin cancer for early diagnosis and prevention of disease with applicable clinical treatments.MethodsThis study compared gene expression and protein levels in ultraviolet-mediated cultured keratinocytes and adjacent normal skin tissue using RNA sequencing data from the National Center for Biotechnology Information-Gene Expression Omnibus (NCBI-GEO) database. Then, pathway analysis was employed with a selection of hub genes from the protein-protein interaction (PPI) network and the survival and expression profiles. Finally, potential clinical biomarkers were validated by receiver operating characteristic (ROC) curve analysis.ResultsWe identified 32 shared differentially expressed genes (DEGs) by analyzing three different subsets of the GSE85443 dataset. Skin cancer development is related to the control of several DEGs through cyclin-dependent protein serine/threonine kinase activity, cell cycle regulation, and activation of the NIMA kinase pathways. The cytoHubba plugin in Cytoscape identified 12 hub genes from PPI; among these 3 DEGs, namely, AURKA, CDK4, and PLK1 were significantly associated with survival (P < 0.05) and highly expressed in skin cancer tissues. For validation purposes, ROC curve analysis indicated two biomarkers: AURKA (area under the curve (AUC) value = 0.8) and PLK1 (AUC value = 0.7), which were in an acceptable range.ConclusionsFurther translational research, including clinical experiments, teratogenicity tests, and in-vitro or in-vivo studies, will be performed to evaluate the expression of these identified biomarkers regarding the prognosis of skin cancer patients.
oncology,biotechnology & applied microbiology
What problem does this paper attempt to address?